What does SAY-CURE-IT do?

SAY-CURE-IT is an IT company in Brussel. Private Limited, started on 12 December 2018, 1 establishment.

What is the address of SAY-CURE-IT?

The registered office of SAY-CURE-IT is located at Robert Schumanplein 6 box 5, 1040 Brussel.

Is SAY-CURE-IT still active?

Yes. According to the CBE (31 October 2026) SAY-CURE-IT is active, legal situation “Normale toestand”, started on 12 December 2018.

Is SAY-CURE-IT registered on Peppol?

Yes, SAY-CURE-IT is registered on the Peppol network with ID 0208:0715734096.

What is the enterprise number of SAY-CURE-IT?

The enterprise number of SAY-CURE-IT is BE0715734096.

When was SAY-CURE-IT founded?

SAY-CURE-IT was founded on 12 December 2018.

Who are the directors of SAY-CURE-IT?

According to the 2024 annual accounts, the directors of SAY-CURE-IT are: Gozie OFULUME.

Is SAY-CURE-IT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 December 2018; 3 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did SAY-CURE-IT make in 2024?

SAY-CURE-IT posted a profit after taxes of € 2,158 in financial year 2024.

What is the revenue of SAY-CURE-IT?

As a small company, SAY-CURE-IT is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 31,466.

SAY-CURE-IT (Private Limited) - Brussel - BE0715734096

Dossier SAY-CURE-IT, printed on 1 November 2026 from databakkes.be/en/0715734096/say-cure-it. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Annual account missing NBB

Fiscal year 2025 was expected before 31 October 2025 and has not been filed.
Busy address KBO

80 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2024

SAY-CURE-IT from Brussel, company number BE0715734096, closed financial year 2024 with a result of € 2,158 after tax. For that financial year SAY-CURE-IT recorded a gross margin of € 31,466 and equity of € 142,008. Compared with financial year 2023, the result moved from € 23,705 to € 2,158. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2024.

What it is worth Growing

€ 142,008

▲ 2% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 2,158

▼ 91% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 31,580

▼ 21% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 135,808.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 14,177

▲ 79% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 10,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 11,587

▼ 71% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 22,330

▼ 30% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 96,465 Gross margin 2022: € 96,465 First fiscal year in the series	€ 42,520 Gross margin 2023: € 42,520 ▼ 56% vs 2022 (€ 96,465) Unfavourable step	€ 31,466 Gross margin 2024: € 31,466 ▼ 26% vs 2023 (€ 42,520) Unfavourable step	▼ 26%
Profit after taxes	€ 49,988 Profit after taxes 2022: € 49,988 First fiscal year in the series	€ 23,705 Profit after taxes 2023: € 23,705 ▼ 53% vs 2022 (€ 49,988) Unfavourable step	€ 2,158 Profit after taxes 2024: € 2,158 ▼ 91% vs 2023 (€ 23,705) Unfavourable step	▼ 91%
Equity	€ 116,145 Equity 2022: € 116,145 First fiscal year in the series	€ 139,850 Equity 2023: € 139,850 ▲ 20% vs 2022 (€ 116,145) Favourable step	€ 142,008 Equity 2024: € 142,008 ▲ 2% vs 2023 (€ 139,850) Favourable step	▲ 2%
Total debts	€ 70,523 Total debts 2022: € 70,523 First fiscal year in the series	€ 88,772 Total debts 2023: € 88,772 ▲ 26% vs 2022 (€ 70,523) Unfavourable step	€ 43,917 Total debts 2024: € 43,917 ▼ 51% vs 2023 (€ 88,772) Favourable step	▼ 51%
Cash	€ 23,729 Cash 2022: € 23,729 First fiscal year in the series	€ 40,184 Cash 2023: € 40,184 ▲ 69% vs 2022 (€ 23,729) Favourable step	€ 31,580 Cash 2024: € 31,580 ▼ 21% vs 2023 (€ 40,184) Unfavourable step	▼ 21%
Land & buildings	€ 129,252 Land & buildings 2022: € 129,252 First fiscal year in the series	€ 133,436 Land & buildings 2023: € 133,436 ▲ 3% vs 2022 (€ 129,252) Unchanged	€ 128,644 Land & buildings 2024: € 128,644 ▼ 4% vs 2023 (€ 133,436) Unchanged	▼ 4%
Retained profit	€ 109,945 Retained profit 2022: € 109,945 First fiscal year in the series	€ 133,650 Retained profit 2023: € 133,650 ▲ 22% vs 2022 (€ 109,945) Favourable step	€ 135,808 Retained profit 2024: € 135,808 ▲ 2% vs 2023 (€ 133,650) Favourable step	▲ 2%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Bank debt 2024: € 10,000 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 186,668 Balance sheet total 2022: € 186,668 First fiscal year in the series	€ 228,622 Balance sheet total 2023: € 228,622 ▲ 22% vs 2022 (€ 186,668) Unchanged	€ 185,925 Balance sheet total 2024: € 185,925 ▼ 19% vs 2023 (€ 228,622) Unchanged	▼ 19%

Key figures of SAY-CURE-IT, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 October 2025.

What happened to SAY-CURE-IT?

What happened at SAY-CURE-IT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 29, 2024 New annual accounts for financial year 2024: profit of € 2,158 (▼ 91% vs 2023). Source: NBB ↗
Dec 12, 2018 New establishment in Brussel. KBO
Dec 12, 2018 Start of the company according to the CBE. KBO

In short

From € 49,988 profit in 2022 to € 2,158 profit in 2024.

Paid € 37,861 in corporate taxes since 2022.

Best year ever: 2022, with € 49,988 profit.

Original PDFs at the National Bank ↗

Management

Gozie OFULUME

SAY-CURE-IT

Behind SAY-CURE-IT is Gozie OFULUME.

Directors

According to the 2024 annual accounts

Gozie OFULUME

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Robert Schumanplein 6 box 5

1040 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 80 companies are registered at this address.

All companies at this address →

GLP Ghent

€ 2.5 million revenue · 2025

BERENSCHOT BELGIUM NV

€ 1.8 million revenue · 2025

FOSS BENELUX

€ 590,599 gross margin · 2022

ESL&Network (European Affairs)

€ 483,388 gross margin · 2025

Association des Constructeurs européens d'Automobiles

€ 16.3 million revenue · 2025

+75 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0715.734.096

VAT number

BE 0715.734.096

Registered office

Robert Schumanplein 6 bus 5, 1040 Brussel

Names & denominations

SAY-CURE-IT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 December 2018

Peppol

Active · Active since 4 Dec 2025

Contact

[email protected]

Activities · NACE

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computerconsultancy-activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

SAY-CURE-IT

Warning lights

Financials

What happened to SAY-CURE-IT?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions